Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05509270 · ClinicalTrials.gov registry record · NA
Efficacy of Communication Modalities for Promoting Flu Shots
A NA study of Health Behavior and Risk Reduction, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 43,225
- Enrollment target
- 1
- Study location
NCT05509270: Completed NA study of Health Behavior and Risk Reduction, sponsored by Geisinger Clinic.
NCT05509270 is a NA study of Health Behavior and Risk Reduction that has completed, run by Geisinger Clinic. The registered enrollment target is 43,225 participants, above the 1,521-participant average among 65 other Health Behavior trials with a reported enrollment target (2742% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05509270, a NA study of Health Behavior and Risk Reduction, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 43,225 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test which modalities (mailed letter, short message service \[SMS\] text, or patient portal messages) are most effective for encouraging flu shots in high-risk patients.
Primary Outcome
Flu vaccination within 4 weeks of the first message send date
Conditions Studied
Interventions
- BEHAVIORAL Letter
- BEHAVIORAL SMS
- BEHAVIORAL Patient portal
Study Locations (1)
Pennsylvania
- Geisinger - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43,225 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2022-10-04 |
| Phase | NA |
What the finished NCT05509270 record still lists
NCT05509270 is an interventional study that assigns participants to a tested intervention. Its 43,225 participants enrollment target places it among the larger protocols in the corpus, above the 1,521-participant average among 65 other Health Behavior trials with a reported enrollment target (2742% higher).
The record links to 4 conditions, with Health Behavior appearing as the primary indexed condition, and to 3 interventions - of which Letter is the first listed.
NCT05509270 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05509270 about?
NCT05509270 is a clinical study titled "Efficacy of Communication Modalities for Promoting Flu Shots". The purpose of this study is to test which modalities (mailed letter, short message service \[SMS\] text, or patient portal messages) are most effective for encouraging flu shots in high-risk patients.
What is the current status of trial NCT05509270?
This trial is currently completed. It is a NA study. The enrollment target is 43,225 participants. The study started on 2022-09-06. Estimated completion is 2022-10-04.
What conditions does trial NCT05509270 study?
This clinical trial studies the following conditions: Health Behavior, Risk Reduction, Health Promotion, Influenza Vaccination.
What interventions are being tested in trial NCT05509270?
The interventions under investigation include: Letter (BEHAVIORAL), SMS (BEHAVIORAL), Patient portal (BEHAVIORAL).
Who is sponsoring clinical trial NCT05509270?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05509270 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05509270's enrollment target sits among peer trials
43,225 2nd of 65 the highest of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05607732 · 45,257 participants · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI